Determination of risk factors affecting mortality in patients with gastrointestinal perforation after pediatric liver transplantation.


Journal

Pediatric transplantation
ISSN: 1399-3046
Titre abrégé: Pediatr Transplant
Pays: Denmark
ID NLM: 9802574

Informations de publication

Date de publication:
06 2019
Historique:
received: 21 11 2018
revised: 04 03 2019
accepted: 12 03 2019
pubmed: 12 4 2019
medline: 22 4 2020
entrez: 12 4 2019
Statut: ppublish

Résumé

Gastrointestinal perforation (GIP) is one of the most serious complications occurring after liver transplantation (LT), especially in pediatric patients. This study aimed to determine the risk factors affecting mortality in pediatric patients with GIP after LT. GIP developed in 37 (10%) of 370 pediatric patients who underwent LT at our institute. Patients were divided into two groups: alive (n = 22) or dead (n = 15), and both groups were compared in terms of demographic and clinical parameters using univariate analysis. There was no statistically significant difference between groups in either demographic or clinical parameters, except for perforation site (P = 0.001) and median follow-up (P = 0.001). Stomas arose in 17 (45.9%) patients: 76% of patients with stomas and 45% of those without survived (P = 0.052). Kaplan-Meier analysis indicated that patients with stomas had a significantly higher overall survival (P = 0.029) and that patients with duodenal and colonic perforation had a significantly lower overall survival. Multivariate analysis showed that re-perforation was an independent risk factor for mortality (P = 0.035; OR: 17.674; 95% CI for OR: 1.233-253.32). Although there are many options for management of GIP, including primary repair, resection plus anastomosis, and resection plus end or loop ostomy, gastrointestinal diversion is still the best option.

Identifiants

pubmed: 30973664
doi: 10.1111/petr.13415
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13415

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Bora Barut (B)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Sami Akbulut (S)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Koray Kutluturk (K)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Cemalettin Koc (C)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Dincer Ozgor (D)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Cemalettin Aydin (C)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Ayse Selimoglu (A)

Department of Pediatric Gastroenterology, Inonu University Faculty of Medicine, Malatya, Turkey.

Sezai Yilmaz (S)

Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH